According to a new report published by Reports Monitor titled, “ Global Bacterial Biochemical Market, Growth Opportunities, Innovations and Forecast, 2018-2025,” the global bacterial biochemical market was valued at XX million in 2018, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025.
Bacterial biochemical identification is the process of identifying harmful and injurious bacteria and fungi that can contaminate raw materials, branded products and manufacturing facilities. The biochemical identification of microorganisms provides an idea of what these microorganisms are capable, being possible the discrimination of different strains of the same species by specific biochemical profiles.
The growth of bacterial biochemical identification market is mainly driven by the widespread of various infectious diseases, technological advancements leading to the introduction of innovative products, and growing awareness towards the food safety. However, the rigid regulatory norms, framework and patient reimbursement situations may hinder the market growth. The increasing awareness and the technological advancements in healthcare and funding by government in research & development might be an opportunity to increase the market growth.
The market on the basis of product type is bifurcated as products and services. Products includes instruments and consumables. Furthermore, it can be classified on the basis of method such as Phenotypic Methods, Genotypic Methods, and Proteomics-based Methods.
Moreover it is segmented as on the basis of application such as Diagnostic Applications (Human Disease Diagnosis, Animal Disease Diagnosis), Food Testing, Beverage Testing, Cosmetics and Personal Care Products Testing, Pharmaceutical Applications, Environmental Application, and Others.
The global bacterial biochemical market is divided on regional basis into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. North America’s market include countries like USA followed by Canada and Mexico and has dominance in the market. Europe shares the same potential, including countries like Germany, France, U.K., and Italy. APAC market share in the global bacterial biochemical identification is expected to grow at a rapid pace due to the heavy expenditure in healthcare sector and technological advancements in countries such as India, Japan, China, Australia and others. LAMEA region is having considerable share in the market and is expected to grow in countries like Brazil, Turkey, and rest of the regions.
The major key players in this market are Dickinson & Company, Bruker Corporation, Becton, Biolog Inc., BioMerieux SA, Life Technologies Corporation, Charles River Laboratories Inc., Siemens Healthcare, MIDI Inc., QIAGEN N.V., Shimadzu Corporation, Sigma-Aldrich Corporation, and VITEK 2 Compact by MiL, AlleleID by Premier Biosoft.
About Garner Insights:
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.